
    
      PRIMARY OBJECTIVE:

      I. To determine the efficacy and toxicity of radiation therapy alone in treating stage 1 and
      2 MALT lymphoma for newly diagnosed patients and for the patients who failed other treatment
      modalities.

      OUTLINE:

      Patients undergo radiation therapy once daily (QD) 5 times weekly over 3.5-5 weeks.

      After completion of study treatment, patients are followed up at 6-8 weeks, and then every
      3-4 months for year 1, every 4-6 months for year 2, every 6 months for years 3 and 4, and
      once yearly thereafter.
    
  